Inhibitors of the enzymatic activity of psa
CA 2274958 A1 · Owner: Neubauer, Blake Lee · Inventors: Becker, Gerald Wayne; Neubauer, Blake Lee; Anderson, Benjamin Alan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is directed to novel azetidinone compounds to certain , intermediates and processes for preparing these azetidinone compounds and to , formulations containing the same. The present invention also relates to the use of these azetidinones as inhibitors of the enzymatic activity of Prostate- Specific Antigen (PSA) as well as for treating prostatic cancer (Pca) Pca , metastasis, benign prostatic hyperplasia (BPH) and breast cancer (Bc). Another aspect of the invention relates to inventive methods for treating Pca Pca , metastasis, BPH and Bc by administering any PSA inhibiting compound.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 9, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 9, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 9, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.